U.S. FDA Approves Pfizer's CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic DermatitisBusiness Wire • 01/14/22
Pfizer And COVID: The Vaccine And Treatment Opportunities Are Still UnderappreciatedSeeking Alpha • 01/13/22
Basilea announces approval of antifungal Cresemba® (isavuconazole) for invasive aspergillosis in ChinaGlobeNewsWire • 01/13/22
3 Growth Stocks That Have Generated $179 Billion in Free Cash Flow in 12 MonthsThe Motley Fool • 01/12/22
Pfizer says its safe and effective to co-administer its Prevnar 20, COVID-19 shotsMarket Watch • 01/12/22
Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults ReleasedBusiness Wire • 01/12/22
Exclusive-Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtualReuters • 01/11/22